Status:

UNKNOWN

Radiotherapy of Multiple Brain Metastases Using AGuIX®

Lead Sponsor:

University Hospital, Grenoble

Collaborating Sponsors:

NH TherAguix SAS

Conditions:

Brain Metastases, Adult

Radiotherapy

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is a Prospective Randomized Open Blinded Endpoint phase II clinical trial. The study will be adaptive: an interim analysis is planned after enrolment of 20 patients in each arm of treatment (WBRT...

Detailed Description

The occurrence of brain metastases is a common event in the history of cancer and negatively affects the life expectancy of patients. Their incidence varies between 15 and 50% according to the histolo...

Eligibility Criteria

Inclusion

  • Patients with brain metastases, from a histologically confirmed solid tumor, eligible for WBRT
  • At least 18 years old
  • Signed informed consent after informing the patient
  • ECOG (Eastern Cooperative Oncology Group) performance status 0-2
  • Extracranial disease:
  • Complete or partial response or stability under systemic treatment
  • No extracranial disease
  • Or first line of treatment
  • Life expectancy greater than 6 weeks
  • Effective contraceptive method for all patient of childbearing potential
  • Affiliated to a social security regimen

Exclusion

  • Leptomeningeal metastasis
  • Evidence of metastasis with recent large hemorrhage
  • Progressive and threatening extracranial disease under systemic treatment
  • Previous cranial irradiation (except stereotactic irradiation)
  • Known contra-indication, sensitivity or allergy to gadolinium
  • Known contra-indication for Magnetic Resonance Imaging
  • Renal insufficiency (glomerular filtration rate ≤ 50 mL/min/1.73m²)
  • Pregnancy or breastfeeding
  • Subject under administrative or judicial control

Key Trial Info

Start Date :

March 26 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 26 2025

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03818386

Start Date

March 26 2019

End Date

March 26 2025

Last Update

June 14 2024

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Institut Régional du Cancer

Montpellier, Occitanie, France, 34298

2

Institut Claudius Regaud Institut Universitaire du Cancer Toulouse Oncopole Radiothérapie

Toulouse, Occitanie, France, 31059

3

Centre Leon Berard Lyon

Lyon, Rhones Alpes, France, 69373

4

Centre Hospitalier Annecy Genevois

Annecy, Rhones-Alpes, France, 74374